Abstract:In this study, six novel benzothiazole derivatives based on the bithiophene structure were developed as potential β-amyloid probes. In vitro binding studies using Aβ aggregates showed that all of them demonstrated high binding affinities with Ki values ranged from 0.11 to 4.64nM. In vitro fluorescent staining results showed that these compounds can intensely stained Aβ plaques within brain sections of APP/PS1 transgenic mice, animal model for AD. Two radioiodinated compounds [125I]-2-(5′-iodo-2,2′-bithiophen-5-yl)-6-methoxybenzo[d]thiazole [125I]10 and [125I]-2-(2,2′-bithiophen-5-yl)-6-iodobenzo[d]thiazole [125I]13 were successfully prepared through an iododestannylation reaction. Furthermore, in vitro autoradiography of the AD model mice brain sections showed that both [125I]10 and [125I]13 labeled the Aβ plaques specifically with low background. In vivo biodistribution studies in normal mice indicated that [125I]13 exhibited high brain uptake (3.42% ID/g at 2min) and rapid clearance from the brain (0.53% ID/g at 60min), while [125I]10 showed lower brain uptake (0.87% ID/g at 2min). In conclusion, these preliminary results of this study suggest that the novel radioiodinated benzothiazole derivative [125I]13 may be a candidate as an in vivo imaging agent for detecting β-amyloid plaques in the brain of AD patients.

2-Phenylbenzothiazole conjugated with cyclopentadienyl tricarbonyl [CpM(CO)3] (M = Re, (99m)Tc) complexes as potential imaging probes for β-amyloid plaques.

2-Arylbenzothiazoles Labeled with [cpre/99mtc(co)3] and Evaluated As Β-Amyloid Imaging Probes.

Novel Cyclopentadienyl Tricarbonyl Complexes of (99m)tc Mimicking Chalcone As Potential Single-Photon Emission Computed Tomography Imaging Probes for Β-Amyloid Plaques in Brain.

(99M)tc-Labeled Dibenzylideneacetone Derivatives As Potential SPECT Probes for in Vivo Imaging of Β-Amyloid Plaque.

Synthesis and biological evaluation of novel technetium-99m labeled phenylbenzoxazole derivatives as potential imaging probes for β-amyloid plaques in brain.

99Mtc-Labeled 2-Arylbenzothiazoles: Aβ Imaging Probes with Favorable Brain Pharmacokinetics for Single-Photon Emission Computed Tomography.

(99M)tc-Labeled-2-arylbenzoxazole Derivatives As Potential Aβ Imaging Probes for Single-Photon Emission Computed Tomography.

99mTc- and Re-labeled 6-dialkylamino-2-naphthylethylidene derivatives as imaging probes for β-amyloid plaques.

99mTc(CO)3-Labeled Benzothiazole Derivatives Preferentially Bind Cerebrovascular Amyloid: Potential Use as Imaging Agents for Cerebral Amyloid Angiopathy

Oligoethyleneoxy-Modified 99Mtc-Labeled Β-Amyloid Imaging Probes with Improved Brain Pharmacokinetics for Single-Photon Emission Computed Tomography.

Tc-99m-Labeled Benzothiazole And Stilbene Derivatives As Imaging Agents For A Beta Plaques In Cerebral Amyloid Angiopathy

Preparation and Biological Evaluation of Re/99 Tcm (CO) 3 +-diphenyldiazene Derivative as Candidates for Imaging Aβ Plaques in the Brain

Synthesis and Biological Evaluation of 99mtc, Re-monoamine-monoamide Conjugated to 2-(4-aminophenyl)benzothiazole As Potential Probes for Β-Amyloid Plaques in the Brain

Synthesis and Bioevaluation of Technetium-99 M / Rhenium Labeled Phenylquinoxaline Derivatives As Tau Imaging Probes.

Binding Affinity of Re(CO)_3Cl(EPBI) for Aβ_(1～40) Aggregates and Evaluation of [~(99)Tc_m(CO)_3]~+-EPBI

Preparation of classical Re/99mTc(CO)3(+) and novel 99mTc(CO)2(NO)2+ cores complexed with flavonol derivatives and their binding characteristics for Abeta(1-40) aggregates.

Radioiodinated Benzimidazole Derivatives As Single Photon Emission Computed Tomography Probes for Imaging of Β-Amyloid Plaques in Alzheimer's Disease

99mTc-labeled benzothiazole and stilbene derivatives as imaging agents for Aβ plaques in cerebral amyloid angiopathy

Novel cyclopentadienyl tricarbonyl (99m)tc complexes containing 1-piperonylpiperazine moiety: potential imaging probes for sigma-1 receptors.

Radiolabeled pyridinyl analogues of dibenzylideneacetone as beta-amyloid imaging probes

Synthesis and evaluation of novel benzothiazole derivatives based on the bithiophene structure as potential radiotracers for β-amyloid plaques in Alzheimer’s disease